Systemic delivery of synapsin‐promoted caveolin‐1 overexpression ameliorates pathological TDP‐43–induced cognitive decline and neurodegenerative changes
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Dongsheng Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, University of California San Diego, La Jolla, California, USA. Hauptthemen laut MEDLINE: Caveolin 1, Synapsins, DNA-Binding Proteins, Cognitive Dysfunction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: U.S. Department of Defense, BLRD VA, NCATS NIH HHS.
Abstract (Originalsprache)
INTRODUCTION Transactive response DNA‐binding protein 43 (TDP‐43) proteinopathy is associated with frontotemporal dementia and Alzheimer's disease (AD). We previously demonstrated that synapsin‐promoted caveolin‐1 ( SynCav1 ) preserves cognitive function in the mouse model of AD. This study investigated the therapeutic potential of SynCav1 in a mouse model of TDP‐43 proteinopathy. METHODS AAV‐PhP.eB‐SynCav1 was delivered systemically to the TDP‐43 A315T mouse, followed by cognitive evaluation and biochemical and ultrastructural analysis of brain tissue. RESULTS SynCav1 exerted robust neuroprotective effects on cognition. Mechanistically, pathological TDP‐43 mislocalized to membrane lipid rafts (MLRs), resulting in decreased MLR‐associated GluN2A expression and degenerative changes in neuronal ultrastructure. In contrast, SynCav1 delivery alleviated TDP‐43 mislocalization on MLRs, stabilized MLR‐associated GluN2A expression, and preserved synaptic ultrastructure. Furthermore, SynCav1 mitigated TDP‐43–induced mitochondrial hyper‐fragmentation and excessive mitochondrial fission signaling. DISCUSSION These findings establish a novel link between TDP‐43 proteinopathy and MLR instability, supporting SynCav1 as a “neuron‐centric” candidate for treating TDP‐43–related neurodegeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, University of California San Diego, La Jolla, California, USA.
- VA San Diego Healthcare System, San Diego, California, USA.
- Department of Neurosciences, University of California San Diego, La Jolla, California, USA.
Förderung
- U.S. Department of Defense
- BLRD VA
- NCATS NIH HHS
- University of California-San Diego
- National Institute of health
- NIH HHS
- U.S. Department of Veterans Affairs
- National Institutes of Health
Zitieren
APA
Wang, D., Ta, V., Wang, H., Ju, J., Wang, C., Chehadeh, C., Torreblanca-Zanca, A., Magaña, Y., Castle, M. J., Wang, S., & Head, B. P. (2026). Systemic delivery of synapsin‐promoted caveolin‐1 overexpression ameliorates pathological TDP‐43–induced cognitive decline and neurodegenerative changes. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71450
Vancouver
Wang D, Ta V, Wang H, Ju J, Wang C, Chehadeh C, et al. Systemic delivery of synapsin‐promoted caveolin‐1 overexpression ameliorates pathological TDP‐43–induced cognitive decline and neurodegenerative changes. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71450
BibTeX
@article{Wang2026,
author = {Wang, Dongsheng and Ta, Vinh and Wang, Hongxia and Ju, Jerica and Wang, Chun and Chehadeh, Christine and Torreblanca-Zanca, Albertina and Magaña, Yessenia and Castle, Michael J and Wang, Shanshan and Head, Brian P},
title = {Systemic delivery of synapsin‐promoted caveolin‐1 overexpression ameliorates pathological TDP‐43–induced cognitive decline and neurodegenerative changes},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71450}
}
EUVIMED